Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04275310 · ClinicalTrials.gov registry record · NA
Microeconomic Intervention to Reduce HIV Transmission in Economically Disadvantaged Transgender Women
A NA study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04275310: Clinical Trial NA study, sponsored by Virginia Commonwealth University.
NCT04275310 is a NA study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04275310, a NA study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this research study is to learn more about the economic situations, discrimination experiences, and risk behaviors of transgender women. The ultimate purpose of the study is to test an intervention to improve financial conditions and reduce HIV risk behaviors in transgender women.
Primary Outcome
Number of participants whose status with respect to employment improves after the intervention.
Interventions
- BEHAVIORAL Microeconomic Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2022-07-20 |
| Est. Completion | 2022-11-17 |
| Phase | NA |
Why NCT04275310 stopped before completion
NCT04275310 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Microeconomic Intervention is the first listed.
NCT04275310 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04275310 about?
NCT04275310 is a clinical study titled "Microeconomic Intervention to Reduce HIV Transmission in Economically Disadvantaged Transgender Women". The purpose of this research study is to learn more about the economic situations, discrimination experiences, and risk behaviors of transgender women. The ultimate purpose of the study is to test an intervention to improve financial conditions and reduce HIV risk behaviors in transgender women.
What is the current status of trial NCT04275310?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2022-07-20. Estimated completion is 2022-11-17.
What interventions are being tested in trial NCT04275310?
The interventions under investigation include: Microeconomic Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04275310?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04275310's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI